Respiratory Infections News

NEW YORK — In this video, Timothy R. Shope, MD, MPH, reviews COVID-19, influenza and respiratory syncytial virus for general pediatricians in outpatient clinics.

Levofloxacin was safe and reduced the risk for multidrug-resistant tuberculosis among children, adolescents and adults by 60% in two phase 3 trials, according to results presented at the Union World Conference on Lung Health.

Americans will have another opportunity to order free COVID-19 tests ahead of the holiday season.

NEW YORK — In this video from the Infectious Diseases in Children Symposium, Red Book editor David W. Kimberlin, MD, talks about updates coming to the 2024 edition of the AAP’s guide for pediatric infectious diseases.

NEW YORK — In this video from the Infectious Diseases in Children Symposium, Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses the importance of pediatricians adopting new pneumococcal vaccines into practice to optimize patient coverage.

NEW YORK — The CDC this week announced the release of more than 77,000 additional doses of nirsevimab to address an ongoing shortage of the monoclonal antibody in the United States.

Influenza activity is increasing in most parts of the United States and is at or above baseline levels in three regions, the CDC reported Monday.

Respiratory syncytial virus incidence rates among pregnant people are lower than those seen in older adults and young children, although researchers say rates are still significant and warrant consideration in vaccine policy decisions.

Researchers identified 16 predictors of infant hospitalization for respiratory syncytial virus and developed a model that clinicians can use to predict an infant’s risk, according to findings published in The Lancet Digital Health.

Many health care personnel working in acute-care hospitals and nursing homes are not up to date on recommended COVID-19 or influenza vaccinations, new study findings suggest.